Testosterone Treatment in Older Men
The DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
status: Published
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Though testosterone therapy improves bone mineral density, lean body mass, erectile function, and anemia, there is inconclusive evidence on the benefits of testosterone therapy on cognitive function, energy levels, blood glucose or lipid levels, and controversy remains around whether testosterone therapy affects the risk of cardiovascular events (6-13).”
From Non-testosterone management of male hypogonadism: an examination of the existing literature (2020) · cites this paper as [8]
In the citing paper
“Though testosterone therapy improves bone mineral density, lean body mass, erectile function, and anemia, there is inconclusive evidence on the benefits of testosterone therapy on cognitive function, energy levels, blood glucose or lipid levels, and controversy remains around whether testosterone therapy affects the risk of cardiovascular events (6-13).”
From Non-testosterone management of male hypogonadism: an examination of the existing literature (2020) · cites this paper as [8]
In the citing paper
“Though testosterone therapy improves bone mineral density, lean body mass, erectile function, and anemia, there is inconclusive evidence on the benefits of testosterone therapy on cognitive function, energy levels, blood glucose or lipid levels, and controversy remains around whether testosterone therapy affects the risk of cardiovascular events (6-13).”
From Non-testosterone management of male hypogonadism: an examination of the existing literature (2020) · cites this paper as [8]
In the citing paper
“Another study on testosterone supplementation for 1 year did not observe improved walking distance in older men with reduced testosterone levels (138).”
From Health Consequences of Sarcopenic Obesity: A Narrative Review (2020) · cites this paper as [138]
Citations
Cites
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
Self-citationEffects of Human Growth Hormone in Men over 60 Years Old
Rudman, D., Feller, A. G., Nagraj, H. S., Gergans, G. A., Lalitha, P. Y., Goldberg, A. F., Schlenker, R. A., Cohn, L., Rudman, I. W., & Mattson, D. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230101 · Cited by 1,555
Identification of late-onset hypogonadism in middle-aged and elderly men
Wu, F. C. W., Tajar, A., Beynon, J. M., Pye, S. R., Silman, A. J., Finn, J. D., O'Neill, T. W., Bartfai, G., Casanueva, F. F., Forti, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0911101 · Cited by 1,544
Adverse Events Associated with Testosterone Administration
Basaria, S., Coviello, A. D., Travison, T. G., Storer, T. W., Farwell, W. R., Jette, A. M., Eder, R., Tennstedt, S., Ulloor, J., Zhang, A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1000485 · Cited by 1,494
Effects of Testosterone Treatment in Older Men
Snyder, P. J., Bhasin, S., Cunningham, G. R., Matsumoto, A. M., Stephens-Shields, A. J., Cauley, J. A., Gill, T. M., Barrett-Connor, E., Swerdloff, R. S., Wang, C., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1506119 · Cited by 890
Self-citationJones, T. H., Arver, S., Behre, H. M., Buvat, J., Meuleman, E., Moncada, I., Morales, A. M., Volterrani, M., Yellowlees, A., Howell, J. D., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1233 · Cited by 548
Muraleedharan, V., Marsh, H., Kapoor, D., Channer, K. S., & Jones, T. H. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0321 · Cited by 389
Testosterone and Aging: Clinical Research Directions
(2004) · National Academies Press eBooks · doi:10.17226/10852 · Cited by 231
Provision or Distribution of Growth Hormone for “Antiaging”: Clinical and Legal Issues
Perls, T. T., Reisman, N. R., & Olshansky, S. J. (2005) · JAMA · doi:10.1001/jama.294.16.2086 · Cited by 99
Ramasamy, R., Scovell, J. M., Kovac, J. R., & Lipshultz, L. I. (2014) · Journal of Urology · doi:10.1016/j.juro.2014.03.089 · Cited by 84
Research works printed but not linked: 4
- 10.7326/0003-4819-151-9-200911030-00151 · doi:10.7326/0003-4819-151-9-200911030-00151 · Paper page
- 10.1056/nejmoa0911101 · DOI · Paper page
- Antonio L, J Clin Endocrinol Metab
- 10.1210/jc.2009-2354 · DOI · Paper page
Cited by
Health Consequences of Sarcopenic Obesity: A Narrative Review
Roh, E., & Choi, K. M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00332 · Cited by 304
“Another study on testosterone supplementation for 1 year did not observe improved walking distance in older men with reduced testosterone levels (138).”
BackgroundCorona, G., Rastrelli, G., Morgentaler, A., Sforza, A., Mannucci, E., & Maggi, M. (2017) · European Urology · doi:10.1016/j.eururo.2017.03.032 · Cited by 223
Isidori, A. M., Aversa, A., Calogero, A. E., Ferlin, A., Francavilla, S., Lanfranco, F., Pivonello, R., Rochira, V., Corona, G., & Maggi, M. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01859-7 · Cited by 182
Testosterone Replacement Therapy: Long-Term Safety and Efficacy
Corona, G., Sforza, A., & Maggi, M. (2017) · The World Journal of Men's Health · doi:10.5534/wjmh.2017.35.2.65 · Cited by 60
Androgens and male sexual function
Corona, G., Rastrelli, G., Vignozzi, L., & Maggi, M. (2022) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2022.101615 · Cited by 57
Obesity, Body Composition, and Sex Hormones: Implications for Cardiovascular Risk
Singh, P., Covassin, N., Marlatt, K. L., Gadde, K. M., & Heymsfield, S. B. (2021) · Comprehensive physiology · doi:10.1002/cphy.c210014 · Cited by 56
Testosterone levels in healthy men correlate negatively with serotonin 4 receptor binding
Perfalk, E., da Cunha‐Bang, S., Holst, K. K., Keller, S. H., Svarer, C., Knudsen, G. M., & Frøkjær, V. G. (2017) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2017.03.018 · Cited by 43
Mirone, V. G., Debruyne, F. M. J., Dohle, G. R., Salonia, A., Sofikitis, N., Verze, P., Fode, M. M., & Chapple, C. R. (2017) · European Urology · doi:10.1016/j.eururo.2017.02.022 · Cited by 45
Monastra, G., Vazquez-Levin, M. H., Espinola, M. S. B., Bilotta, G., Laganà, A. S., & Unfer, V. (2021) · Basic and Clinical Andrology · doi:10.1186/s12610-021-00131-x · Cited by 43
Non-testosterone management of male hypogonadism: an examination of the existing literature
Krzastek, S. C., & Smith, R. P. (2020) · Translational Andrology and Urology · doi:10.21037/tau.2019.11.16 · Cited by 33
“Though testosterone therapy improves bone mineral density, lean body mass, erectile function, and anemia, there is inconclusive evidence on the benefits of testosterone therapy on cognitive function, energy levels, blood glucose or lipid levels, and controversy remains around whether testosterone therapy affects the r…”
BackgroundRole of Testosterone in the Treatment of Cardiovascular Disease
Webb, C. M., & Collins, P. (2017) · European Cardiology Review · doi:10.15420/ecr.2017:21:1 · Cited by 31
Corona, G., Rastrelli, G., Sparano, C., Carinci, V., Casella, G., Vignozzi, L., Sforza, A., & Maggi, M. (2024) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2024.2337741 · Cited by 28
Rais, M., Wilson, R. M., Urbanski, H. F., & Messaoudi, I. (2017) · GeroScience · doi:10.1007/s11357-017-9979-5 · Cited by 22
Effects of testosterone on circadian rhythmicity in old mice
Hashimoto, A., Fujiki, S., Nakamura, W., & Nakamura, T. J. (2019) · The Journal of Physiological Sciences · doi:10.1007/s12576-019-00695-4 · Cited by 15
Abildgaard, J., Petersen, J. H., Bang, A. K., Aksglæde, L., Christiansen, P., Juul, A., & Jørgensen, N. (2021) · Andrology · doi:10.1111/andr.13124 · Cited by 13
Is Testosterone Replacement Safe in Men with Cardiovascular Disease?
Ahmed, T., Alattar, M., Pantalone, K. M., & Haque, R. U. (2020) · Cureus · doi:10.7759/cureus.7324 · Cited by 12
Anabolic hormone profiles in elite military men: Robust associations with age, stress, and fatigue
Taylor, M. K., Padilla, G. A., & Hernández, L. M. (2017) · Steroids · doi:10.1016/j.steroids.2017.05.010 · Cited by 7
Testosterone and sexual function
Fugh‐Berman, A., & Scialli, A. R. (2017) · Current Opinion in Urology · doi:10.1097/mou.0000000000000438 · Cited by 3
Kandil, N. T., Sabry, D. A., Ashry, N. I., & El‐Sayyad, H. I. (2021) · Food Bioscience · doi:10.1016/j.fbio.2021.101369 · Cited by 3
Hypopituitarism: Replacement of Adrenal, Thyroid, and Gonadal Axes
Levy, M. J., Bhake, R. C., & Reddy, N. (2022) · doi:10.1093/med/9780198870197.003.0021
Risks of Testosterone Treatment
Dobs, A. S., & Yalamanchi, S. (2022) · doi:10.1093/med/9780198870197.003.0490
The Role of Post-Radical Prostatectomy Testosterone Therapy in Erectile Function Recovery
Huynh, L. M., Gevorkyan, R., & Ahlering, T. E. (2022) · Androgens Clinical Research and Therapeutics · doi:10.1089/andro.2022.0005
Scaled Testosterone: A Novel Metric to Calibrate Serum Testosterone and SHBG in MenPreprint
Handelsman, D. J., Wittert, G., Yeap, B. B., Muir, C., PhD Leon Flicker, M. B. B. S., Fui, M. N. T., & Grossmann, M. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.23.727352
Zhu, X., Zhang, X., Xiang, J., & Jiang, C. (2026) · Steroids · doi:10.1016/j.steroids.2026.109804
Metadata
- Authors
- Snyder, P. J., Ellenberg, S. S., & Farrar, J. T.
- Affiliations
- KU Leuven (BE)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-07-07
- Volume
- 375
- Issue
- 1
- Pages
- 88-90
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2502105044
- Cited by
- 25
- References
- 16
- Citations by year
- 2026: 2 · 2024: 1 · 2022: 6 · 2021: 4 · 2020: 3 · 2019: 1 · 2017: 8
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Lirias (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Keywords
- testosterone replacement therapy, older men, androgen deficiency, hypogonadism
- MeSH terms
- Fatigue, Humans, Male, Sexual Behavior, Testosterone, Walking, Hormone Replacement Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.